Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
US-based pharmaceutical company Eli Lilly & Co. announced on 6 November 2006 its plans to close its research laboratories at Hamburg (Germany), Mont-Saint-Guibert (Belgium) and Basingstoke (UK). Whereas there are no further data available on the Belgish and UK locations, the company announced that the closure of the Hamburg laboratory is due to the small size of the German unit and the strategic decision not to invest in its future expansion. Research activites in Germany will be limited to clinical testing of medicines. Apart from this, Eli Lilly is expanding its operations in Germany. A new head quarter is built at Bad Homburg and at Giessen a logistics center is under construction. The company currently employs 1,400 people in Germany.
Eurofound (2006), Eli Lilly, Internal restructuring in Germany, factsheet number 64386, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/64386.